Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
NuVasive (NUVA) Lags Q2 Earnings Estimates
10:15pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
NuVasive (NUVA) delivered earnings and revenue surprises of -14.55% and 1.51%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio
09:00am, Tuesday, 02'nd Aug 2022 GlobeNewswire Inc.
MARTINSRIED, Germany and LEIPZIG, Germany, Aug. 02, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced the acquisition of Leipzig-based company mementor; the deal was completed
Semiconductor Shortages - See How ResMed Is Tackling
06:15pm, Friday, 22'nd Jul 2022 Benzinga
ResMed Inc (NYSE: RMD) has redesigned the AirSense 10 to eliminate a short-supply semiconductor chipset used for cellular communications chips.
Instead of offering wireless communications capabilit
ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022
08:05pm, Thursday, 14'th Jul 2022 GlobeNewswire Inc.
SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2022 on Thursday
ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022
04:05pm, Thursday, 14'th Jul 2022
SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2022 on Thursday,
AngioDynamics (ANGO) Q4 Earnings in Line, Revenues Beat Mark
02:29pm, Wednesday, 13'th Jul 2022 Zacks Investment Research
AngioDynamics (ANGO) registers strong revenue growth in Med Tech and Med Device businesses, as well as in its GBUs, in fourth-quarter fiscal 2022.
Reasons Why You Should Invest in ResMed (RMD) Stock Now
05:04pm, Wednesday, 06'th Jul 2022 Zacks Investment Research
Investors are optimistic about ResMed's (RMD) robust mask and device sales and continued product innovations.
Reasons Why You Should Invest in ResMed (RMD) Stock Now
02:45pm, Wednesday, 06'th Jul 2022
Investors are optimistic about ResMed's (RMD) robust mask and device sales and continued product innovations.
NUVA vs. RMD: Which Stock Should Value Investors Buy Now?
03:40pm, Tuesday, 05'th Jul 2022 Zacks Investment Research
NUVA vs. RMD: Which Stock Is the Better Value Option?
NUVA vs. RMD: Which Stock Should Value Investors Buy Now?
01:13pm, Tuesday, 05'th Jul 2022
NUVA vs. RMD: Which Stock Is the Better Value Option?
7 Growth Stocks to Buy in July 2022
09:29am, Monday, 04'th Jul 2022
The severe macroeconomic climate has led investors toward defensive plays, creating buy opportunities in the following growth stocks. The post 7 Growth Stocks to Buy in July 2022 appeared first on Inv
Should iShares Morningstar MidCap Growth ETF (IMCG) Be on Your Investing Radar?
10:20am, Monday, 27'th Jun 2022 Zacks Investment Research
Style Box ETF report for IMCG
ResMed (RMD) Inks Deal to Acquire MEDIFOX DAN in Germany
03:00pm, Wednesday, 15'th Jun 2022 Zacks Investment Research
ResMed's (RMD) acquisition of a renowned out-of-hospital software solutions company is expected to strengthen its SaaS business.
ResMed (RMD) Inks Deal to Acquire MEDIFOX DAN in Germany
12:20pm, Wednesday, 15'th Jun 2022
ResMed's (RMD) acquisition of a renowned out-of-hospital software solutions company is expected to strengthen its SaaS business.
ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions
06:05am, Tuesday, 14'th Jun 2022 GlobeNewswire Inc.
SAN DIEGO and HILDESHEIM, Germany, June 14, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced a definitive agreement to acquire privately held MEDIFOX DAN, a German leader in out
